2023 Review: Chinese-Sponsored Phase III US Trials See Uptick

But Still Below '21 Level

 
• By Dexter Jie Yan
  
Clinical study
Chinese drug makers stem fall in number of new US Phase III trials • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia